IRIS
CAMPOCHIARO, CORRADO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.451
NA - Nord America 2.033
AS - Asia 1.584
SA - Sud America 271
AF - Africa 34
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.376
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.960
RU - Federazione Russa 1.223
SG - Singapore 615
CN - Cina 484
RO - Romania 435
IT - Italia 268
BR - Brasile 216
HK - Hong Kong 163
VN - Vietnam 157
DE - Germania 115
FR - Francia 93
GB - Regno Unito 68
SE - Svezia 58
CA - Canada 46
FI - Finlandia 44
IN - India 41
NL - Olanda 28
AT - Austria 27
JP - Giappone 24
ES - Italia 23
PL - Polonia 23
AR - Argentina 22
MX - Messico 20
ZA - Sudafrica 16
BD - Bangladesh 15
TR - Turchia 15
LT - Lituania 14
ID - Indonesia 9
IQ - Iraq 8
KR - Corea 8
PK - Pakistan 8
EC - Ecuador 7
PY - Paraguay 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
CO - Colombia 6
NO - Norvegia 6
VE - Venezuela 6
CL - Cile 5
KE - Kenya 5
LU - Lussemburgo 5
PH - Filippine 5
EG - Egitto 4
IE - Irlanda 4
SA - Arabia Saudita 4
TN - Tunisia 4
UA - Ucraina 4
LV - Lettonia 3
MA - Marocco 3
MY - Malesia 3
PT - Portogallo 3
AU - Australia 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
IL - Israele 2
KZ - Kazakistan 2
MD - Moldavia 2
TW - Taiwan 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BE - Belgio 1
BG - Bulgaria 1
BS - Bahamas 1
CH - Svizzera 1
CR - Costa Rica 1
EU - Europa 1
GE - Georgia 1
HR - Croazia 1
IR - Iran 1
LC - Santa Lucia 1
MG - Madagascar 1
SI - Slovenia 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
Totale 6.376
Salva come PNG Salva come JPEG
Città #
Dallas 930
Singapore 369
Moscow 230
Ashburn 205
Hong Kong 156
San Jose 134
Beijing 106
Shanghai 78
Milan 67
Los Angeles 66
New York 61
Hefei 58
Ho Chi Minh City 55
Lauterbourg 50
Munich 39
Boardman 36
Nuremberg 33
Hanoi 28
Santa Clara 24
Denver 22
Orem 22
São Paulo 22
Tokyo 21
Council Bluffs 20
Brooklyn 17
Helsinki 17
Montreal 17
Phoenix 17
Poplar 17
Warsaw 17
Chicago 16
Rome 15
Amsterdam 14
Guangzhou 14
Johannesburg 14
Lappeenranta 14
Stockholm 14
Chennai 13
Frankfurt am Main 13
Turku 13
Falkenstein 12
Atlanta 11
Houston 11
Toronto 10
Boston 9
Buffalo 9
London 9
Rio de Janeiro 9
Ankara 8
City of London 8
Da Nang 8
Lawrence 8
Naples 8
Princeton 8
Seongnam-si 8
Vaprio d'Adda 8
Vienna 8
Cesano Boscone 7
Haiphong 7
Mugnano di Napoli 7
New Delhi 7
Secaucus 7
Tashkent 7
Xi'an 7
Belo Horizonte 6
Bergamo 6
Mumbai 6
Oslo 6
Porto Alegre 6
Querétaro 6
Shenzhen 6
St Louis 6
Ancona 5
Cagliari 5
Esch-sur-Alzette 5
Hải Dương 5
Kassel 5
Mexico City 5
Nairobi 5
Padua 5
Paris 5
Roubaix 5
Bexley 4
Hangzhou 4
Manchester 4
Quito 4
Romagnano Sesia 4
San Francisco 4
Seattle 4
Segrate 4
The Dalles 4
Tianjin 4
Turin 4
Alessandria 3
Amadora 3
Angera 3
Annapolis 3
Asunción 3
Augusta 3
Baghdad 3
Totale 3.438
Salva come PNG Salva come JPEG
Nome #
Digital Ulcers and Ventricular Arrhythmias as Red Flags to Predict Replacement Myocardial Fibrosis in Systemic Sclerosis 453
Intercalated Disc Abnormalities Are Linked to Arrhythmias in Inflammatory Cardiomyopathy 423
Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study 344
Monkeypox in a patient with undifferentiated connective tissue disease 249
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 180
Myocarditis in anti-synthetase syndrome: clinical features and diagnostic modalities 141
Does the impact of COVID-19 on patients with systemic sclerosis change over time? 125
Cardiac magnetic resonance findings in acute and post-acute COVID-19 patients with suspected myocarditis 124
Liquid biopsy of cerebrospinal fluid enabling the detection and therapeutic targeting of the BRAFV600E mutation in a patient with overlapping Erdheim-Chester/Rosai-Dorfman disease 123
Adherence to the Mediterranean Diet in Italian Patients With Systemic Sclerosis: An Epidemiologic Survey 116
Clinical profiling and outcomes of viral myocarditis manifesting with ventricular arrhythmias 115
Distinctive clinical traits of lupus-related myocarditis: a multicentre retrospective study 115
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease 113
Cardiovascular involvement in Erdheim-Chester diseases is associated with myocardial fibrosis and atrial dysfunction 112
Case report: Cytopenias in VEXAS syndrome - a WHO 2022 based approach in a single-center cohort 110
CD4+ Memory Stem T Cells Recognizing Citrullinated Epitopes Are Expanded in Patients With Rheumatoid Arthritis and Sensitive to Tumor Necrosis Factor Blockade 109
Case report: Successful use of mepolizumab for immune checkpoint inhibitors–induced hypereosinophilic syndrome in two patients with solid malignancies 105
A Multinational Survey Investigating the Unmet Needs and Patient Perspectives Concerning Proton Pump Inhibitors in Systemic Sclerosis 103
La misurazione quantitativa dell’uptake di 18F-FDG in TC/PET riflette l’espansione dei plasmablasti circolanti nella malattia IgG4 correlata 103
Clinical Applications of FDG-PET Scan in Arrhythmic Myocarditis 102
High-dose anakinra in addition to standard of care including corticosteroids in patients with severe COVID-19 treated with non-invasive ventilation 102
Calcinosis in systemic sclerosis: An update on pathogenesis, related complications, and management: A heavy burden still waiting to be lifted off patients’ hands 101
Myelomonocytic cells in giant cell arteritis activate trained immunity programs sustaining inflammation and cytokine production 99
Canakinumab as first-line biological therapy in Still’s disease and differences between the systemic and the chronic-articular courses: Real-life experience from the international AIDA registry 98
Anakinra for the Treatment of Antisynthetase Syndrome: A Monocentric Case Series and a Systematic Literature Review 98
Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation 98
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase 98
A multi-national survey to identify clinicians’ perspectives concerning Proton Pump inhibitors in patients with systemic sclerosis 96
Effectiveness of a two-year tapered course of tocilizumab in patients with giant cell arteritis: A single-centre prospective study 94
Giant cell arteritis: Update on clinical manifestations, diagnosis, and management 94
Drug development and novel therapeutics to ensure a personalized approach in the treatment of systemic sclerosis 94
Rituximab retention rate in systemic sclerosis: a long term real-life multicentre study 93
Efficacy and safety of apremilast for Behçet's syndrome: a real-life single-centre Italian experience 93
Efficacy and safety of rituximab biosimilar (CT-P10) in IgG4-related disease: an observational prospective open-label cohort study 92
Systemic sclerosis Progression INvestiGation (SPRING) Italian registry: demographic and clinico-serological features of scleroderma spectrum 91
Multimodal Detection and Targeting of Biopsy-Proven Myocardial Inflammation in Genetic Cardiomyopathies: A Pilot Report 90
Cardiac involvement, a threatening very early manifestation of systemic sclerosis: evidence from VEDOSS patients 89
Extracellular vesicles and interstitial lung disease in systemic sclerosis: State of the art! 88
Cardiac Sarcoidosis: Clinical Insights, Diagnosis, and Management Strategies 85
Mechanisms of hematopoietic clonal dominance in VEXAS syndrome 83
Interstitial lung disease in limited cutaneous systemic sclerosis patients: never let your guard down 83
Effectiveness and safety of mycophenolate mofetil and rituximab combination therapy for immune idiopathic myopathies 80
VEXAS associated acute disseminated Encephalo-Myelitis (ADEM)-like syndrome: A case report and review of the literature 77
Inflammatory rheumatic diseases with onset after SARS-CoV-2 infection or COVID-19 vaccination: a report of 267 cases from the COVID-19 and ASD group 77
Systemic sclerosis myocarditis has unique clinical, histological and prognostic features: a comparative histological analysis 72
Towards a comprehensive approach to the management and prognosis of systemic sclerosis's patients: The role of comorbidities in the SPRING-SIR registry 71
Corrigendum to “Intravenous immunoglobulins reduce skin thickness in systemic sclerosis: evidence from Systematic Literature Review and from real life experience” [Autoimmunity Reviews, Volume 20, Issue 12, December 2021, 102981](S1568997221002615)(10.1016/j.autrev.2021.102981) 70
Beyond very early systemic sclerosis: deciphering pre‑scleroderma and its trajectories to open new avenues for preventive medicine 69
HETEROGENEITY OF CYTOPENIAS IN VEXAS SYNDROME: A SINGLE CENTRE EXPERIENCE 68
Ventricular Arrhythmias in Myocarditis: Characterization and Relationships With Myocardial Inflammation 68
Systemic pharmacological treatment of digital ulcers in systemic sclerosis: a systematic literature review 64
Unraveling the Pathogenesis of Calcinosis in Systemic Sclerosis: A Molecular and Clinical Insight 53
Open questions on the management of targeted therapies for the treatment of systemic sclerosis-interstitial lung disease: results of a EUSTAR survey based on a systemic literature review 53
Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry 'SPRING' of the Italian Society for Rheumatology 52
Surgical management of digital ulcers in systemic sclerosis: A systematic literature review 52
Non-surgical local treatments of digital ulcers in systemic sclerosis: a systematic literature review 51
Doppler ultrasound, a noninvasive tool for the study of mesenteric arterial flow in systemic sclerosis: a cross-sectional study of a patient cohort with review and meta-analysis of the literature 50
Sex influence on outcomes of patients with systemic sclerosis-associated interstitial lung disease: a EUSTAR database analysis 49
Successful use of ixekizumab for glucocorticoid-free remission maintenance in giant cell arteritis 48
Practice pattern for the use of intravenous iloprost for the treatment of peripheral vasculopathy in systemic sclerosis: A case–control study from the Italian national multicenter “SPRING” (Systemic Sclerosis Progression InvestiGation) Registry 44
Is cyclophosphamide still the gold standard in early severe rapidly progressive systemic sclerosis? 38
Doppler ultrasound unveils splanchnic arteries ischemia allowing early successful revascularization in symptomatic systemic sclerosis patients 33
Recombinant human hyaluronidase-facilitated subcutaneous immunoglobulin (hf-SCIg) for inflammatory myositis: a multicenter retrospective real-world observational study 22
Real-life use of high-dose anakinra in patients with COVID-19 treated with remdesivir 6
Totale 6.591
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.474
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.474
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 0 0 0 0 2 1
2021/202231 0 0 3 3 1 8 2 2 5 3 2 2
2022/2023109 19 16 9 0 0 13 28 14 4 0 5 1
2023/2024314 4 13 15 30 25 48 38 38 3 18 28 54
2024/20251.457 55 14 39 62 54 89 585 114 132 90 90 133
2025/20264.668 304 608 673 539 392 141 362 343 1.115 191 0 0
Totale 6.591